Hepion Pharmaceuticals to be Added to the Russell Microcap® Index
EDISON, N.J., June 09, 2021 (GLOBE NEWSWIRE) -- Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA, “Hepion”), a clinical stage biopharmaceutical company focused on...
News
Aleafia Health Establishes At-the-Market Equity Program
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, June 09, 2021 (GLOBE...
KemPharm to be Added to Russell 2000® and Russell 3000® Indexes Effective June 28, 2021
CELEBRATION, Fla., June 09, 2021 (GLOBE NEWSWIRE) -- KemPharm, Inc. (NASDAQ: KMPH), a specialty pharmaceutical company focused on the discovery and...
VitalHub Announces Sale to University Hospitals Coventry and Warwickshire NHS Trust
TORONTO, June 09, 2021 (GLOBE NEWSWIRE) -- VitalHub Corp. (the “Company” or “VitalHub”) (TSXV: VHI) is pleased to announce the...
Adamis Provides Update on ZIMHI™
FDA Deems New Drug Application for ZIMHI Complete and Establishes a Target Action Date of November 12, 2021SAN DIEGO, June...
Inozyme Announces Acceptance of First European Clinical Trial Application for Phase 1/2 Clinical Trial of INZ-701 in ABCC6 Deficiency
- Clinical trial initiation expected in mid-2021 –- Preliminary safety and biomarker data expected by the end of 2021 -...
OpGen Group Company Ares Genetics Presents at AWS and Twist Bioscience Webinars
ROCKVILLE, Md., June 09, 2021 (GLOBE NEWSWIRE) -- OpGen, Inc. (Nasdaq: OPGN, “OpGen”), a precision medicine company harnessing the power...
Generation Bio to Present at the JMP Securities Life Sciences Conference
CAMBRIDGE, Mass., June 09, 2021 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO), an innovative genetic medicines company creating a...
Brooklyn ImmunoTherapeutics Set to Join Russell 3000 Index
BROOKLYN, N.Y., June 09, 2021 (GLOBE NEWSWIRE) -- Brooklyn ImmunoTherapeutics, Inc. (NYSE American: BTX) ("Brooklyn"), a biopharmaceutical company focused on...
New Study Published in Nature Provides Further Evidence that COVID-19 Vaccine Induced T-Cell Response Targets Known SARS-CoV-2 Variants of Concern
Adaptive’s immunoSEQ T-MAP COVID provides potential explanation for preservation of Johnson & Johnson vaccine (Ad26.COV2.S) response to variants even when...
Auxly Announces $15.0 Million Bought-Deal Public Offering
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, June 09, 2021 (GLOBE NEWSWIRE) --...
Clearside Biomedical to Participate in Two Upcoming Investor Conferences in June 2021
ALPHARETTA, Ga., June 09, 2021 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company dedicated to developing and delivering treatments...
The Joint Corp. Enters New Market, Opening the First Clinic in a Series of Six Planned Corporate Clinics
Clinics Included in the May 6 Guidance of Opening 20 to 30 Corporate Clinics in 2021SCOTTSDALE, Ariz., June 09, 2021...
CareDx congratulates Hannah Valantine for her State of the Art Lecture at ATC on Transplant Equity
Valantine’s ATC Presentation Highlights the Role of AlloMap and AlloSure on Inclusive Research and DevelopmentSOUTH SAN FRANCISCO, Calif., June 09,...
TG Therapeutics Announces Data Presentations at the Upcoming 16th International Congress on Malignant Lymphoma
NEW YORK, June 09, 2021 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the schedule of upcoming data...
Trillium Announces Voting Results From the Annual General and Special Meeting of Shareholders
CAMBRIDGE, Mass., June 09, 2021 (GLOBE NEWSWIRE) -- Trillium Therapeutics Inc. (NASDAQ/TSX: TRIL) (the “Corporation”), a clinical stage immuno-oncology company...
Sio Gene Therapies Announces Fiscal Year 2020 Year-End Financial Results and Expected Fiscal Year 2021 Key Milestones
– Multiple GM1 gangliosidosis program milestones expected in FY2021, including 12-month data updates from the ongoing dose-escalation study and meeting...
Athira Pharma to Present at Upcoming Investor Conferences
– JMP Securities Life Sciences Conference – Raymond James Human Health Innovation Conference BOTHELL, Wash., June 09, 2021 (GLOBE NEWSWIRE)...
Trevena to Present at the JMP Securities Life Sciences Conference
CHESTERBROOK, Pa., June 09, 2021 (GLOBE NEWSWIRE) -- Trevena, Inc. (TRVN), a biopharmaceutical company focused on the development and commercialization...
Halberd Corporation Undertakes Process Toward the Elimination of Alzheimer’s Disease
Jackson Center, Pennsylvania--(Newsfile Corp. - June 9, 2021) - Halberd Corporation (OTC Pink: HALB) commences experimentations to eradicate three of...